Henry Schein, Inc. (NASDAQ:HSIC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $79.30.

A number of brokerages have weighed in on HSIC. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Barrington Research cut their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of HSIC. Olstein Capital Management L.P. boosted its stake in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Private Management Group Inc. lifted its position in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after buying an additional 18,882 shares in the last quarter. Equitable Trust Co. bought a new stake in Henry Schein during the 4th quarter worth about $417,000. Savant Capital LLC grew its holdings in Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after acquiring an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after acquiring an additional 3,650 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Up 2.1%

Henry Schein stock opened at $71.54 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a fifty day moving average price of $67.36 and a two-hundred day moving average price of $71.45. The firm has a market cap of $8.71 billion, a price-to-earnings ratio of 29.44, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the previous year, the firm earned $1.10 EPS. The firm's revenue was down .1% compared to the same quarter last year. As a group, analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.